Daycare center at Central Taiwan University of Science and Technology
Taichung, Taiwan
NCT Number: NCT05720416
1. To develop a multiactivity training programme. 2. To explore the effect of this programme on sarcopenia, sarcopenic obesity, cognitive impairment and Parkinson's disease. 3. To compare the effects of the experimental and control treatments on the muscle strength, body composition, physical function performance and quality of life of the elderly.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Taichung, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(1) over 60 years old, (2) able to Communicate and follow instructions; (3) Stable condition with sufficient physical strength: able to maintain a seated position in a wheelchair or on the edge of a bed for at least one hour. (4) sarcopenia, sarcopenic obesity, cognitive impairment and Parkinson's disease.
Exclusion criteria
(1) difficulty in standing or walking and obvious musculoskeletal disease, (2) unsuitable for diagnosis by a physician those engaged in sports activities, (3) serious diseases/unstable states, such as severe heart, lung, liver and kidney diseases, severe malignant tumors, severe nutrition poor, severe dementia, (4) more than 180 minutes of exercise per week in the past month, (5) no willingness to participate.
protein supplementation for 16 weeks
muscle strength training for 16 weeks
no intervention
Time frame: Baseline and 16 weeks
pinch, grip and quadriceps strength. A Higher score means a better outcome.
Time frame: Baseline and 16 weeks
muscle mass(kg), fat mass (kg)
Time frame: Baseline and 16 weeks
This is a scale of physical function. The range for total score is 0-100. A Higher score means a worse outcome.
Time frame: Baseline and 16 weeks
This is a scale of physical function. The range for total score is 0-24. A Higher score means a better outcome.
Time frame: Baseline and 16 weeks
Mental Function Assessment. The range is 0-3. A Higher score means a worse outcome.
Time frame: Baseline and 16 weeks
Mental Function Assessment. The range for total score is 0-38. A Higher score means a worse outcome.
Time frame: Baseline and 16 weeks
This is a scale of behavior measurement. The range for total is 29-203. A higher score means a worse outcome.
Time frame: Baseline and 16 weeks
This is a scale of quality of life. The range for total is 0-20. A higher score means a worse outcome.
Time frame: Baseline and 16 weeks
The scale is a dementia-specific Qol instrument. The range for total score is 0-120. A higher score means a better outcome.
Time frame: Baseline
Gender, education, age, married status, religion, medication, diseases, work and height.
Time frame: Baseline and 16 weeks
The range for total is 0-80. A higher score means a better outcome.
Time frame: Baseline and 16 weeks.
The range for total is 0-70. A higher score means a better outcome.
Time frame: Baseline and 16 weeks.
This is a scale of quality of life. The range for total is 26-130. A higher score means a better outcome.
Time frame: Baseline and 16 weeks.
Measured with seconds. A higher score means a worse outcome.
Central Taiwan University of Science and Technology
Other
Effects of a Multi-intervention Programme on the Muscle Strength, Body Composition, Physical Performance and Quality of Life of the Elderly
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07275177
Age-Related Loss of Skeletal Muscle Mass, Aging
Miahuatlán de Porfirio Díaz, Oaxaca, Mexico
View Trial DetailsNCT06895122
Atrophy, Behavior
Salamanca, Spain
View Trial DetailsNCT05631379
Atrophy, Body Composition
Ljubljana, Slovenia
View Trial DetailsNCT03871634
Atrophy, Body Weight
Athens, Kallithea, Greece
View Trial Details